Advanced search
Publication Cover
Seminars in Ophthalmology Volume 32, 2017 - Issue 5
Submit an article Journal homepage
600
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications

Wen-Shi ShiehMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USACorrespondence[email protected]
View further author information
,
Jayanth SridharMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Bryan K. HongMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Joseph I. MaguireMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Ehsan RahimyMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Abtin ShahlaeeMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Allen C. HoMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Jason HsuMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
,
Carl D. RegilloMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
&
Allen ChiangMid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USAView further author information
 show all
Pages 614-619 | Received 27 Sep 2015, Accepted 03 Jan 2016, Published online: 01 Jul 2016

REFERENCES

  • Barnes GD, Ageno W, Ansell J, Kaatz S; Subcommittee on the Control of Anticoagulation. Recommendation on the nomenclature for oral anticoagulants: Communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(6):1154–6.
  • Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit C, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Varheugt FWA, Zhu J, Wallentin L. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11): 981–92.
  • Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.
  • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KAA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.
  • Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J. 2010;160(4):635–41.
  • Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol. 2012;110(3):453–60.
  • Caldeira D, Canastro M, Barra M, Ferreira A, Costa J, Pinto FJ, Ferreira JJ. Risk of substantial intraocular bleeding with novel oral anticoagulants: Systematic review and meta-analysis. JAMA Ophthalmol. 2015;133:7:834–9.
  • Jun JH, Hwang JC. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage. JAMA Ophthalmol. 2015;133:10:1184–6.
  • Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc. 2006;104:149–60.
  • Fu AD, McDonald HR, Williams DF, Cantrill HL, Ryan EH Jr, Johnson RN, Ai E, Jumper JM. Anticoagulation with warfarin in vitreoretinal surgery. Retina 2007 Mar;27(3):290–5.
  • Jamula E, Anderson J, Douketis JD. Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis. Thromb Res. 2009 Jul;124(3):292–9.
  • Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361(24):2342–52.
  • Nguyen TM, Phelan MP, Werdich XQ, Rychwalski PJ, Huff CM. Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa). Am J Emerg Med. 2013 Feb;31(2):455.e3–5.
  • Kang TS, Lord K, Kunjukunju N. Spontaneous choroidal hemorrhage in a patient on dabigatran etexilate (Pradaxa). Retin Cases Brief Rep. 2014;8(3):175–7.
  • Roehrig S, Straub A, Pohlmann J, Lampe T, Pernerstorfer J, Schlemmer KH, Reinemer P, Perzborn E. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939): An oral, direct factor Xa inhibitor. J Med Chem. 2005 Sep 22;48(19):5900–8.
  • Bayer Schering Pharma AG. Xarelto: Summary of product characteristics. https://www.xarelto-us.com/shared/product/xarelto/prescribing-information.pdf
  • Beck RA, King WM 4th. Apixaban (eliquis) for stroke prevention in atrial fibrillation. Am Fam Physician 2014 Apr 15;89(8):672–5.
  • Providencia R, Grove EL, Husted S, Barra S, Boveda S, Morais J. A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: Comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens. Thromb Res. 2014 Dec;134(6):1253–64.
  • Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: A systematic review and meta-analysis. JAMA. 2014 Sep 17;312(11):1122–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.